Adaptive Biotechnologies Corporation
NASDAQAdaptive Biotechnologies enters the post-earnings period with a notable internal tension: short sellers are stepping back, yet the company's own President and COO has been selling shares every single trading day for the past two weeks. Short interest has been on a clear downward path. At roughly 6.7% of the free float, it has fallen from a peak near 7.7% in late March — a near-13%…
Snapshot as of 6 May 2026
Adaptive Biotechnologies enters the post-earnings period with a notable internal tension: short sellers are stepping back, yet the company's own President and COO has been selling shares every single trading day for…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ADPT — free to start on ORTEX.
Sign up for free →Open ADPT on ORTEX